1. Home
  2. WVE vs ASTH Comparison

WVE vs ASTH Comparison

Compare WVE & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$16.01

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

HOLD

Current Price

$23.68

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
ASTH
Founded
2012
1994
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
WVE
ASTH
Price
$16.01
$23.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
9
Target Price
$27.53
$41.33
AVG Volume (30 Days)
12.9M
489.7K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$109,230,000.00
$2,896,452,000.00
Revenue This Year
N/A
$58.37
Revenue Next Year
$31.09
$25.48
P/E Ratio
N/A
$122.28
Revenue Growth
103.75
68.17
52 Week Low
$5.28
$20.12
52 Week High
$21.73
$39.97

Technical Indicators

Market Signals
Indicator
WVE
ASTH
Relative Strength Index (RSI) 65.75 49.51
Support Level $6.93 $20.64
Resistance Level $21.73 $23.23
Average True Range (ATR) 1.51 0.95
MACD 1.14 0.35
Stochastic Oscillator 61.45 94.93

Price Performance

Historical Comparison
WVE
ASTH

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Share on Social Networks: